Eli Lilly & Company recalls Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 4…
- Recall date
- August 19, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0773-2021
- FDA classification
- Class II
- Brand / firm
- Eli Lilly & Company
- Sold / distributed
- USA Nationwide
Why it was recalled
Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80
Get recall alerts
Free email alert whenever Eli Lilly & Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Eli Lilly & Company